Here are five quick facts:
1. Oppenheimer set a $28 price target for Globus Medical shares.
2. Globus Medical currently has a “buy” rating.
3. There is a potential upside of 12.22 percent.
4. Globus Medical traded up 0.6 percent yesterday mid-day.
5. Market cap for the company is $2.36 million with a P/E ratio of 25.72.
Recently, WallachBeth Capital raised the price target on Globus to $30 from $26 and also gave the company a “buy” rating earlier this month. Leerink Swann also raised target price to $29 and gave the company an “outperform” rating, according to the report.
More articles on orthopedic devices:
Greatbatch short interest drops by 8.5% — 4 things to know
Amedica to present CASCADE clinical results
Spine device stock report: 5 key companies
